China’s technology sector pressured by increased regulatory concerns; US Treasuries weaken as US economy gathers pace; Japan equities rally fuelled by stimulus, BoJ moves. China’s markets weighed down by underperforming vaccine makers after Brazil’s health regulator suspended a Sinovac vaccine trial.
The Dow Jones surged after Pfizer said its coronavirus vaccine would have an efficacy of 90%, spurring gains across the board on hopes it could usher an end to economy-wrecking pandemic lockdowns. Asia Times Financial TV reports.
04 Vaccine halt concern
Brazil’s suspension of the trial of a Covid-19 vaccine by China’s Sinovac has highlighted geopolitical strains in the race to tackle the pandemic, as investors continue to digest Pfizer’s announcement of test success
Shares in Shanghai listed cable-maker soar after it pays a big premium for Luo Yongchao's internet sales company; meanwhile, the Consumers Association issues a warning over the risks of e-commerce sales and product quality as another Single's Day bonanza looms.